@NP	Study	1
@NP	the Ef ciency	10
@NP	Transplantation of Human Neural Stem Cells to Rats with Spinal Trauma	28
@NP	Transplantation	28
@NP	Human Neural Stem Cells to Rats with Spinal Trauma	47
@NP	Human Neural Stem Cells	47
@NP	Rats with Spinal Trauma	74
@NP	Rats	74
@NP	Spinal Trauma	84
@NP	the Use of Functional Load Tests and BBB Test S.	99
@NP	the Use	99
@NP	Functional Load Tests and BBB Test S.	110
@NP	Functional Load Tests	110
@NP	BBB Test S.	136
@NP	V.	149
@NP	Lebedev , A.	152
@NP	Lebedev	152
@NP	A.	161
@NP	V.	164
@NP	Karasev , V.	167
@NP	Karasev	167
@NP	V.	176
@NP	P.	179
@NP	Chekhonin , E.	182
@NP	Chekhonin	182
@NP	E.	193
@NP	A.	196
@NP	Savchenko , I.	199
@NP	Savchenko	199
@NP	I.	210
@NP	V.	213
@NP	Viktorov , Yu .	216
@NP	Viktorov	216
@NP	Yu	226
@NP	A.	230
@NP	Chelyshev * , and G.	233
@NP	Chelyshev	233
@NP	* , and G.	242
@NP	*	242
@NP	G.	249
@NP	F.	252
@NP	Translated from Byulleten ' Eksperimental ' noi	271
@NP	Translated	271
@NP	Byulleten ' Eksperimental ' noi	287
@NP	Byulleten '	287
@NP	i	325
@NP	Meditsiny , Vol	327
@NP	149 , No. 3 ,	343
@NP	149	343
@NP	355-360 , March , 2010	359
@NP	355-360	359
@NP	March , 2010	368
@NP	March	368
@NP	2010	375
@NP	Original article	381
@NP	April 29 , 2009	408
@NP	Human ensheating neural stem cells of the olfactory epithelium	426
@NP	Human ensheating neural stem cells	426
@NP	the olfactory epithelium	464
@NP	adult male rats	510
@NP	contusion trauma	544
@NP	the spinal cord at T9 level rostrally and caudally to the injury	564
@NP	the spinal cord	564
@NP	T9 level	583
@NP	the injury	618
@NP	Voluntary movements -LRB- by a 21-point BBB scale -RRB-	630
@NP	Voluntary movements	630
@NP	a 21-point BBB scale	654
@NP	rota-rod performance	677
@NP	a narrowing beam	717
@NP	60 days	761
@NP	rats	773
@NP	cell transplantation	788
@NP	the mean BBB score	810
@NP	11 %	856
@NP	the end of the experiment	863
@NP	the end	863
@NP	the experiment	874
@NP	The mean parameters of load tests	890
@NP	The mean parameters	890
@NP	load tests	913
@NP	the corresponding parameters	949
@NP	controls	981
@NP	The efficiency of transplantation	991
@NP	The efficiency	991
@NP	transplantation	1009
@NP	percent of animals with motor function recovery parameters	1026
@NP	percent	1026
@NP	animals with motor function recovery parameters	1037
@NP	animals	1037
@NP	motor function recovery parameters	1050
@NP	the corresponding mean values	1096
@NP	the control groups	1129
@NP	62 %	1153
@NP	the state of voluntary motions	1160
@NP	the state	1160
@NP	voluntary motions	1173
@NP	37 % by the rota-rod test	1192
@NP	37 %	1192
@NP	the rota-rod test	1199
@NP	32 % by the narrowing beam test	1222
@NP	32 %	1222
@NP	the narrowing beam test	1229
@NP	Morphometry	1254
@NP	considerable shrinking	1275
@NP	the zone	1301
@NP	traumatic damage	1313
@NP	the spinal cord and activation of posttraumatic remyelination	1333
@NP	the spinal cord and activation	1333
@NP	posttraumatic remyelination	1367
@NP	animals receiving transplantation of human neural stem cells	1398
@NP	animals	1398
@NP	transplantation of human neural stem cells	1416
@NP	transplantation	1416
@NP	human neural stem cells	1435
@NP	Fundamental studies	1461
@NP	the tissue	1484
@NP	cellular levels in the field of experimental cell therapy of spinal traumas	1499
@NP	cellular levels	1499
@NP	the field of experimental cell therapy of spinal traumas	1518
@NP	the field	1518
@NP	experimental cell therapy of spinal traumas	1531
@NP	experimental cell therapy	1531
@NP	spinal traumas	1560
@NP	the existence	1585
@NP	a considerable reparative potential	1602
@NP	transplanted preparations of stem -LRB- progenitor -RRB- cells	1641
@NP	transplanted preparations	1641
@NP	stem -LRB- progenitor -RRB- cells	1670
@NP	stem -LRB- progenitor -RRB-	1670
@NP	stem	1670
@NP	progenitor	1676
@NP	cells	1688
@NP	functional recovery of motor functions -LRB- organism level -RRB-	1699
@NP	functional recovery	1699
@NP	motor functions -LRB- organism level -RRB-	1722
@NP	motor functions	1722
@NP	organism level	1739
@NP	minimum -LSB- 5,6,11 -RSB-	1759
@NP	This discrepancy	1777
@NP	methodical problems	1814
@NP	particular	1838
@NP	subjectivity	1852
@NP	the method	1868
@NP	semiquantitative evaluation	1882
@NP	voluntary motions -LRB- BBB test -RRB- used in practically all studies	1913
@NP	voluntary motions	1913
@NP	BBB test	1932
@NP	practically all studies	1950
@NP	the error of the method according to authors ' estimation	1975
@NP	the error	1975
@NP	the method according to authors ' estimation	1988
@NP	the method	1988
@NP	authors ' estimation	2012
@NP	authors '	2012
@NP	1-2 points	2044
@NP	the 21-point scale -LSB- 4 -RSB-	2059
@NP	the 21-point scale	2059
@NP	4 -RSB-	2079
@NP	various reports	2096
@NP	the maximum improvement	2113
@NP	the motor functions	2140
@NP	this scale	2163
@NP	transplantation	2180
@NP	cell preparations	2199
@NP	animals with contusion traumas of the spinal cord -LRB- CTSC -RRB-	2220
@NP	animals	2220
@NP	contusion traumas of the spinal cord -LRB- CTSC -RRB-	2233
@NP	contusion traumas	2233
@NP	the spinal cord -LRB- CTSC -RRB-	2254
@NP	the spinal cord	2254
@NP	CTSC	2271
@NP	2-3 points	2292
@NP	the control -LSB- 3,5-7,9-11,13 -RSB-	2315
@NP	the control	2315
@NP	3,5-7,9-11,13 -RSB-	2328
@NP	The problem	2344
@NP	functional load tests	2379
@NP	objective evaluation of motor function recovery , physical working capacity	2410
@NP	objective evaluation	2410
@NP	motor function recovery , physical working capacity	2434
@NP	motor function recovery	2434
@NP	physical working capacity	2459
@NP	adaptive capacities of the whole orga nism	2490
@NP	adaptive capacities	2490
@NP	the whole orga nism	2513
@NP	2 -RSB-	2534
@NP	we	2543
@NP	this methodological approach	2553
@NP	preclinical evaluation	2586
@NP	the efficiency	2612
@NP	transplanta tion of neural stem cells -LRB- NSC -RRB- of human olfactory mucosa	2630
@NP	transplanta tion	2630
@NP	neural stem cells -LRB- NSC -RRB- of human olfactory mucosa	2650
@NP	neural stem cells -LRB- NSC -RRB-	2650
@NP	neural stem cells	2650
@NP	NSC	2669
@NP	human olfactory mucosa	2677
@NP	rats in acute period of CTSC	2703
@NP	rats	2703
@NP	acute period of CTSC	2711
@NP	acute period	2711
@NP	CTSC	2727
@NP	MATERIALS AND METHODS	2734
@NP	Experiments	2756
@NP	53	2788
@NP	albino male rats	2799
@NP	300-350 g	2825
@NP	standard conditions of experimental biological clinics	2852
@NP	standard conditions	2852
@NP	experimental biological clinics	2875
@NP	free access	2912
@NP	food and water	2927
@NP	The olfactory epithelium tissue	2943
@NP	Neurovita hospital	2991
@NP	patients	3015
@NP	spinal traumas	3029
@NP	the procedure	3045
@NP	Ethical committee of Russian State Medical University	3075
@NP	Ethical committee	3075
@NP	Russian State Medical University	3096
@NP	Fragments of the olfactory mucosa -LRB- 10 × 5 mm -RRB-	3131
@NP	Fragments	3131
@NP	the olfactory mucosa -LRB- 10 × 5 mm -RRB-	3144
@NP	the olfactory mucosa	3144
@NP	10 × 5 mm	3166
@NP	10 ×	3166
@NP	5 mm	3169
@NP	the upper portion of the superior turbinate	3193
@NP	the upper portion	3193
@NP	the superior turbinate	3214
@NP	local lidocaine anesthesia	3243
@NP	The tissue sample	3271
@NP	the laboratory in cold Ca2	3308
@NP	the laboratory	3308
@NP	cold Ca2	3326
@NP	+	3334
@NP	Mg2	3336
@NP	+	3339
@NP	free Hanks saline	3341
@NP	antibiotics and antimycotics -LRB- 1:100 , Gibco -RRB- not later than 2 h	3370
@NP	antibiotics and antimycotics -LRB- 1:100 , Gibco -RRB-	3370
@NP	antibiotics and antimycotics	3370
@NP	1:100	3400
@NP	Gibco	3407
@NP	2 h	3429
@NP	isolation	3439
@NP	The samples	3450
@NP	the same buffer	3490
@NP	blood vessels	3507
@NP	the tissue	3539
@NP	trypsin and EDTA -LRB- 0.25 % -RRB-	3580
@NP	trypsin and EDTA	3580
@NP	0.25 %	3598
@NP	0.01 M phosphate buffered saline -LRB- pH 7.4 -RRB- at 36.5 oC for 40 min	3608
@NP	0.01 M phosphate	3608
@NP	saline -LRB- pH 7.4 -RRB-	3634
@NP	saline	3634
@NP	pH 7.4	3642
@NP	36.5 oC for 40 min	3653
@NP	36.5 oC	3653
@NP	40 min	3664
@NP	The enzymes	3672
@NP	DMEM -LRB- Gibco -RRB- containing 3 % serum	3702
@NP	Gibco	3708
@NP	3 % serum	3726
@NP	the tissue	3736
@NP	3 times	3758
@NP	balanced Hanks saline	3771
@NP	repeated pipetting in a nutrient medium	3812
@NP	repeated pipetting	3812
@NP	a nutrient medium	3834
@NP	Nutrient media	3853
@NP	the following composition	3872
@NP	DMEM/F12 -LRB- Gibco -RRB-	3899
@NP	DMEM/F12	3899
@NP	Gibco	3909
@NP	10 % FCS -LRB- Gibco -RRB-	3917
@NP	10 % FCS	3917
@NP	Gibco	3926
@NP	2 mM glutamine -LRB- Gibco -RRB-	3934
@NP	2 mM glutamine	3934
@NP	Gibco	3950
@NP	0.8 % glucose , insulin + transferrin	3958
@NP	0.8 %	3958
@NP	glucose , insulin + transferrin	3963
@NP	sodium selenute -LRB- Gibco , 1:100 -RRB- , 20 mM HEPES	3992
@NP	sodium selenute	3992
@NP	Gibco	4009
@NP	1:100	4016
@NP	20 mM HEPES	4024
@NP	growth factors -LRB- only for primary cultures -RRB-	4041
@NP	growth factors	4041
@NP	primary cultures	4066
@NP	fibroblast growth factor -LRB- 1 ng/ml ; Sigma -RRB- and nerve growth factor	4085
@NP	fibroblast growth factor -LRB- 1 ng/ml ; Sigma -RRB-	4085
@NP	fibroblast growth factor	4085
@NP	1 ng/ml ; Sigma	4111
@NP	1 ng/ml	4111
@NP	Sigma	4120
@NP	nerve growth factor	4131
@NP	2 ng/ml ; Sigma	4152
@NP	2 ng/ml	4152
@NP	Sigma	4161
@NP	The cell suspension	4169
@NP	1200 rpm for 7 min	4208
@NP	1200 rpm	4208
@NP	7 min	4221
@NP	the pellet	4231
@NP	the same medium	4261
@NP	Only cell suspensions containing 90-95 % viable cells	4278
@NP	Only cell suspensions	4278
@NP	90-95 % viable cells	4311
@NP	90-95 %	4311
@NP	further culturing	4345
@NP	cells	4376
@NP	12-well plates	4399
@NP	polylysine-coated substrate for 14 h.	4417
@NP	polylysine-coated substrate	4417
@NP	14 h.	4449
@NP	The medium	4455
@NP	twice a week	4484
@NP	The primary culture after attaining a confluent state	4498
@NP	The primary culture	4498
@NP	a confluent state	4534
@NP	trypsin-EDTA -LRB- 0.25 % -RRB-	4571
@NP	trypsin-EDTA	4571
@NP	0.25 %	4585
@NP	Hanks balanced saline solution -LRB- HBSS -RRB-	4603
@NP	Hanks balanced saline solution	4603
@NP	HBSS	4635
@NP	nutrient medium	4674
@NP	The cell suspension	4691
@NP	25	4730
@NP	cm flasks	4734
@NP	the substrate neurospheres	4777
@NP	enzyme treatment	4838
@NP	Suspension of neurosphere cells	4856
@NP	Suspension	4856
@NP	neurosphere cells	4870
@NP	glial cells	4928
@NP	fibroblasts	4941
@NP	stromal -LRB- supportive -RRB- cells attached to the substrate	4958
@NP	stromal -LRB- supportive -RRB- cells	4958
@NP	the substrate	4997
@NP	The cultures	5012
@NP	4 times	5047
@NP	A portion of cells of the last passages	5056
@NP	A portion	5056
@NP	cells of the last passages	5069
@NP	cells	5069
@NP	the last passages	5078
@NP	liquid nitrogen	5121
@NP	The composition of NSC preparation	5138
@NP	The composition	5138
@NP	NSC preparation	5157
@NP	immunocytochemical analysis of passage 3 neurospheres	5190
@NP	immunocytochemical analysis	5190
@NP	passage 3 neurospheres	5221
@NP	subsequent 2-week culturing after defrosting	5248
@NP	subsequent 2-week culturing	5248
@NP	defrosting	5282
@NP	Cells of neurospheres	5294
@NP	Cells	5294
@NP	neurospheres	5303
@NP	nestin -LRB- neuronfilament protein -RRB- and B-tubulin	5336
@NP	nestin	5336
@NP	neuronfilament protein	5344
@NP	B-tubulin	5372
@NP	3-fold washout of NSC in cold -LRB- 4 °C -RRB- Hanks saline , cell viability	5388
@NP	3-fold washout	5388
@NP	NSC in cold -LRB- 4 °C -RRB- Hanks saline , cell viability	5406
@NP	NSC	5406
@NP	cold -LRB- 4 °C -RRB- Hanks saline , cell viability	5413
@NP	cold -LRB- 4 °C -RRB- Hanks saline	5413
@NP	4 °C	5419
@NP	cell viability	5438
@NP	trypan blue exclusion test	5470
@NP	trypan	5470
@NP	blue exclusion test	5477
@NP	this parameter	5498
@NP	> 95 %	5517
@NP	>	5517
@NP	a suspension	5527
@NP	cells concentration of 100,000 cells per 1 ml Hanks saline was prepared	5545
@NP	cells concentration	5545
@NP	100,000 cells per 1 ml Hanks saline was prepared	5568
@NP	100,000 cells	5568
@NP	1 ml Hanks saline was prepared	5586
@NP	1 ml	5586
@NP	Hanks saline	5591
@NP	Sterile preparation of NSC	5618
@NP	Sterile preparation	5618
@NP	NSC	5641
@NP	5 min	5665
@NP	the operation room	5685
@NP	transplantation	5717
@NP	1.5	5748
@NP	this period	5762
@NP	the preparation	5774
@NP	4 °C	5804
@NP	CTSC	5809
@NP	8 -RSB-	5850
@NP	The rats	5854
@NP	5 % ketamine -LRB- 120 mg/kg -RRB- and 0.5 % seduxen -LRB- 5 mg/kg -RRB-	5902
@NP	5 % ketamine -LRB- 120 mg/kg -RRB-	5902
@NP	5 % ketamine	5902
@NP	120 mg/kg	5915
@NP	0.5 % seduxen -LRB- 5 mg/kg -RRB-	5930
@NP	0.5 % seduxen	5930
@NP	5 mg/kg	5944
@NP	laminectomy at Th9 level	5960
@NP	laminectomy	5960
@NP	Th9 level	5975
@NP	the spine	5986
@NP	metal clips	6019
@NP	the spinous processes of vertebrae Th8 and Th10	6034
@NP	the spinous processes	6034
@NP	vertebrae Th8 and Th10	6059
@NP	vertebrae Th8	6059
@NP	Th10	6077
@NP	contusion of the spinal cord	6089
@NP	contusion	6089
@NP	the spinal cord	6102
@NP	a metal rod	6135
@NP	2 mm in diameter , 10 mg	6148
@NP	2 mm	6148
@NP	diameter , 10 mg	6156
@NP	diameter	6156
@NP	10 mg	6166
@NP	a stereotaxis micromanipulator	6182
@NP	a height of 12.5 mm	6241
@NP	a height	6241
@NP	12.5 mm	6253
@NP	The epicenter of the damage	6262
@NP	The epicenter	6262
@NP	the damage	6279
@NP	the central line of the spinal cord	6305
@NP	the central line	6305
@NP	the spinal cord	6325
@NP	the boundary with Th8	6344
@NP	the boundary	6344
@NP	Th8	6362
@NP	Th8 laminectomy	6373
@NP	NSC	6409
@NP	two points at the bondaries	6436
@NP	two points	6436
@NP	the bondaries	6450
@NP	Th7 and Th10	6469
@NP	the cranial injection	6483
@NP	0.3 mm	6514
@NP	the left and the caudal one 0.3 mm	6524
@NP	the left	6524
@NP	the caudal one 0.3 mm	6537
@NP	the right from the central line	6562
@NP	the right	6562
@NP	the central line	6577
@NP	damage	6603
@NP	the central channel of the spinal cord	6613
@NP	the central channel	6613
@NP	the spinal cord	6636
@NP	We	6653
@NP	750,000 cells in 10 µl Hanks medium in each point , i.e. 1.5 mln cells per rat	6665
@NP	750,000 cells	6665
@NP	10 µl	6682
@NP	Hanks medium in each point	6688
@NP	Hanks medium	6688
@NP	each point	6704
@NP	1.5 mln cells per rat	6721
@NP	1.5 mln cells	6721
@NP	rat	6739
@NP	experimental group	6744
@NP	30 rats	6776
@NP	Controls -LRB- 23 rats -RRB-	6786
@NP	Controls	6786
@NP	23 rats	6796
@NP	Hanks solution	6814
@NP	the same conditions	6835
@NP	Hamilton syringe	6856
@NP	a steel needle -LRB- G29 -RRB- connected to a micropump	6878
@NP	a steel needle	6878
@NP	G29	6894
@NP	a micropump	6912
@NP	o.	6936
@NP	The cells	6950
@NP	a depth of 1.2 mm	6977
@NP	a depth	6977
@NP	1.2 mm	6988
@NP	the rate of needle introduction	6996
@NP	the rate	6996
@NP	needle introduction	7008
@NP	10 µ/sec	7032
@NP	the rate of injection	7042
@NP	the rate	7042
@NP	injection	7054
@NP	1 µl/min	7068
@NP	The needle	7078
@NP	5 min	7103
@NP	the end of transplantation	7115
@NP	the end	7115
@NP	transplantation	7126
@NP	The operation wound	7143
@NP	sutured layer-by-layer	7167
@NP	Antibiotics	7191
@NP	postoperation days 1-3	7233
@NP	postoperation days	7233
@NP	1-3	7252
@NP	voiding	7257
@NP	the abdominal wall	7288
@NP	the urinary bladder	7313
@NP	The rats	7334
@NP	the same time of the day for 2 consecutive days	7365
@NP	the same time	7365
@NP	the day for 2 consecutive days	7382
@NP	the day	7382
@NP	2 consecutive days	7394
@NP	day	7417
@NP	1 voluntary movements by the BBB test	7421
@NP	1 voluntary movements	7421
@NP	the BBB test	7446
@NP	coordination disturbances by the narrowing beam test	7463
@NP	coordination disturbances	7463
@NP	the narrowing beam test	7492
@NP	day	7537
@NP	2 rota-rod performance	7541
@NP	2 -RSB-	7579
@NP	Morphological studies	7583
@NP	a biomaterial taken 7 , 30 , and 60 days after trauma	7625
@NP	a biomaterial	7625
@NP	7 , 30 , and 60 days	7645
@NP	7	7645
@NP	30	7648
@NP	60 days	7656
@NP	trauma	7670
@NP	The animals	7678
@NP	200 mg/kg ketamine intraperitoneally	7707
@NP	200 mg/kg	7707
@NP	ketamine intraperitoneally	7717
@NP	ketamine	7717
@NP	perfused transcardially with cold -LRB- 4oC -RRB- 4 % paraformaldehyde	7746
@NP	4oC	7781
@NP	phosphate buffer -LRB- pH 7.4 -RRB-	7809
@NP	phosphate buffer	7809
@NP	pH 7.4	7827
@NP	a fragment	7840
@NP	spinal cord	7854
@NP	the vertebrae	7871
@NP	5 cm fragment length , 2.5 cm caudally and caudally from the lesion epicenter	7886
@NP	5 cm fragment length	7886
@NP	2.5 cm caudally and caudally from the lesion epicenter	7908
@NP	2.5 cm	7908
@NP	caudally and caudally from the lesion epicenter	7915
@NP	the lesion	7942
@NP	12 h	7981
@NP	the fragment	7987
@NP	5 portions -LRB- 1 cm each -RRB-	8017
@NP	5 portions	8017
@NP	1 cm each	8029
@NP	1 cm	8029
@NP	each	8034
@NP	the caudal one	8075
@NP	Fragments 1 , 3 , and 5	8091
@NP	2.5 % glutaraldehyde and 1 % OsO4	8131
@NP	2.5 % glutaraldehyde	8131
@NP	1 % OsO4	8155
@NP	epon 812	8191
@NP	Fragments 2 and 4	8201
@NP	Fragments	8201
@NP	2 and 4	8211
@NP	10 % neutral formalin , dehydrated , and embedded in paraffin	8233
@NP	10 % neutral formalin	8233
@NP	paraffin	8283
@NP	The area of pathological cavities	8293
@NP	The area	8293
@NP	pathological cavities	8305
@NP	the amount of myelinated fibers at distances of 3 and 5 mm rostrally	8331
@NP	the amount	8331
@NP	myelinated fibers at distances of 3 and 5 mm rostrally	8345
@NP	myelinated fibers	8345
@NP	distances of 3 and 5 mm rostrally	8366
@NP	distances	8366
@NP	3 and 5 mm rostrally	8379
@NP	3 and 5 mm	8379
@NP	the epicenter of lesion	8413
@NP	the epicenter	8413
@NP	lesion	8430
@NP	semithin sections	8455
@NP	the spinal cord prepared on an LKB III microtome and stained with methylene blue	8476
@NP	the spinal cord	8476
@NP	an LKB III microtome	8504
@NP	methylene blue	8542
@NP	The area	8558
@NP	the white and gray matter	8570
@NP	distances of 1 and 1.5 cm from the epicenter of the lesion	8599
@NP	distances	8599
@NP	1 and 1.5 cm from the epicenter of the lesion	8612
@NP	1 and 1.5 cm	8612
@NP	the epicenter of the lesion	8630
@NP	the epicenter	8630
@NP	the lesion	8647
@NP	paraffin sections	8674
@NP	Morphometrical parameters	8693
@NP	4 zones of the white matter	8737
@NP	4 zones	8737
@NP	the white matter	8748
@NP	ventromedial part	8769
@NP	the anterior funiculus adjacent to the medial fissure on the right side	8790
@NP	the anterior funiculus	8790
@NP	the medial fissure on the right side	8825
@NP	the medial fissure	8825
@NP	the right side	8847
@NP	2 -RRB- the same on the left side	8863
@NP	the same	8866
@NP	the left side	8878
@NP	3 -RRB- lateral part of the lateral funiculus within the frontal plane	8893
@NP	lateral part	8896
@NP	the lateral funiculus within the frontal plane	8912
@NP	the lateral funiculus	8912
@NP	the frontal plane	8941
@NP	the central channel , right side ; 4 -RRB- the same on the left side	8975
@NP	the central channel	8975
@NP	right side ; 4 -RRB- the same on the left side	8996
@NP	right side	8996
@NP	4 -RRB- the same on the left side	9008
@NP	the same	9011
@NP	the left side	9023
@NP	fluorescent visualization of the transplanted cells	9042
@NP	fluorescent visualization	9042
@NP	the transplanted cells	9071
@NP	500,000 NSC stained with CFDA-SE -LRB- Invitrogen -RRB- in 5 µl Hanks medium	9095
@NP	500,000 NSC	9095
@NP	CFDA-SE -LRB- Invitrogen -RRB- in 5 µl Hanks medium	9120
@NP	CFDA-SE -LRB- Invitrogen -RRB-	9120
@NP	CFDA-SE	9120
@NP	Invitrogen	9129
@NP	5 µl Hanks	9144
@NP	5 experimental rats	9183
@NP	2 above described points	9208
@NP	2	9208
@NP	described points	9216
@NP	The cells	9234
@NP	transplantation	9276
@NP	this end	9296
@NP	NSC	9306
@NP	1 mM CFDA-SE in DMSO -LRB- 1:100 -RRB-	9328
@NP	1 mM CFDA-SE	9328
@NP	DMSO -LRB- 1:100 -RRB-	9344
@NP	DMSO	9344
@NP	1:100	9350
@NP	phosphate	9360
@NP	saline for 15 min	9379
@NP	saline	9379
@NP	15 min	9390
@NP	37 °C and then	9400
@NP	37 °C	9400
@NP	then	9409
@NP	DMEM for 30 min at 37oC	9417
@NP	DMEM	9417
@NP	30 min at 37oC	9426
@NP	30 min	9426
@NP	37oC	9436
@NP	The fragment of the spinal cord	9442
@NP	The fragment	9442
@NP	the spinal cord	9458
@NP	day 7	9487
@NP	cryostat sections	9518
@NP	The data	9537
@NP	Student 's t , Wilcoxon -- White , Mann-Whitney , x2 and Fisher exact tests	9581
@NP	Student 's t , Wilcoxon	9581
@NP	Student 's t	9581
@NP	Student 's	9581
@NP	Wilcoxon	9594
@NP	White , Mann-Whitney , x2 and Fisher exact tests	9603
@NP	White	9603
@NP	Mann-Whitney	9610
@NP	x2	9624
@NP	Fisher exact tests	9631
@NP	RESULTS	9652
@NP	1	9666
@NP	Efficiency of NSC	9669
@NP	Efficiency	9669
@NP	NSC	9683
@NP	the Acute Period of CTSC in Rats -LRB- 60 Days after Trauma -RRB- Fig. 1	9706
@NP	the Acute Period	9706
@NP	CTSC	9726
@NP	Rats -LRB- 60 Days after Trauma -RRB- Fig.	9734
@NP	60 Days after Trauma	9740
@NP	60 Days	9740
@NP	Trauma	9754
@NP	1	9768
@NP	Dynamics	9771
@NP	functional tests	9783
@NP	transplantation	9806
@NP	NSC	9825
@NP	human olfactory mucosa	9834
@NP	rats	9860
@NP	the acute period	9868
@NP	CTSC	9888
@NP	a -RRB- voluntary movements by the BBB scale	9894
@NP	a -RRB- voluntary movements	9894
@NP	the BBB scale	9920
@NP	rota-rod holding	9938
@NP	-LRB- 21 rpm -RRB- ; c -RRB- distance	9955
@NP	21 rpm -RRB- ; c	9956
@NP	21 rpm -RRB-	9956
@NP	c	9965
@NP	error-free walking on the narrowing beam	9980
@NP	error-free walking	9980
@NP	the narrowing beam	10002
@NP	CTSC+H	10025
@NP	anks saline	10031
@NP	anks	10031
@NP	-LRB- control -RRB- ; 2 -RRB- CTSC+NSC transplantation	10043
@NP	-LRB- control -RRB-	10043
@NP	2 -RRB- CTSC+NSC transplantation	10054
@NP	p	10084
@NP	< 0.05 compared to the control .	10085
@NP	<	10085
@NP	0.05	10086
@NP	the control	10103
@NP	Fig. 2 .	10117
@NP	Fig.	10117
@NP	2	10122
@NP	Effect	10125
@NP	NSC transplantation	10135
@NP	nervous tissue recovery in rats with CTSC 30 days	10158
@NP	nervous tissue recovery	10158
@NP	rats with CTSC 30 days	10185
@NP	rats	10185
@NP	CTSC	10195
@NP	30 days	10200
@NP	surgery and transplantation	10214
@NP	a , b -RRB-	10243
@NP	a	10243
@NP	total area of cavities	10249
@NP	total area	10249
@NP	cavities	10263
@NP	c , d -RRB- amount	10273
@NP	myelinated fibers ; a , c -RRB- 3 mm caudally	10289
@NP	myelinated fibers	10289
@NP	a	10308
@NP	c	10311
@NP	3 mm	10314
@NP	the lesion epicenter	10331
@NP	b , d	10353
@NP	b	10353
@NP	d	10356
@NP	5 mm	10359
@NP	bars : experiment ; dark bars : control	10370
@NP	bars	10370
@NP	experiment ; dark bars	10376
@NP	experiment	10376
@NP	dark bars	10388
@NP	control	10399
@NP	p	10409
@NP	< 0.05 compared to the control .	10410
@NP	<	10410
@NP	0.05	10411
@NP	the control	10428
@NP	Animal mortality	10442
@NP	the control and experimental groups	10486
@NP	the control	10486
@NP	experimental groups	10502
@NP	26 and 23 % , respectively	10523
@NP	26 and 23 %	10523
@NP	26	10523
@NP	23 %	10530
@NP	Transplantation of NSC	10550
@NP	Transplantation	10550
@NP	NSC	10569
@NP	little effect on body weight gain	10577
@NP	little effect	10577
@NP	body weight gain	10594
@NP	body weight by the end of the experiment	10612
@NP	body weight	10612
@NP	the end of the experiment	10627
@NP	the end	10627
@NP	the experiment	10638
@NP	448 ± 12 g in the control group and 449 ± 15 g	10657
@NP	448 ± 12 g in the control group	10657
@NP	448 ±	10657
@NP	12 g in the control group	10661
@NP	12 g	10661
@NP	the control group	10669
@NP	449 ± 15 g	10691
@NP	449 ±	10691
@NP	15 g	10695
@NP	the experimental group	10703
@NP	BBB testing	10727
@NP	gradual partial spontaneous recovery of voluntary movements	10748
@NP	gradual partial spontaneous recovery	10748
@NP	voluntary movements	10788
@NP	rats of the control group	10811
@NP	rats	10811
@NP	the control group	10819
@NP	BBB score	10838
@NP	7.8 ± 0.2 one	10863
@NP	week	10875
@NP	surgery	10886
@NP	12.5 ± 0.3	10897
@NP	the end of the experiment -LRB- Fig. 1 , a -RRB-	10909
@NP	the end	10909
@NP	the experiment -LRB- Fig. 1 , a -RRB-	10920
@NP	the experiment	10920
@NP	Fig. 1 , a	10936
@NP	Fig. 1	10936
@NP	a	10944
@NP	rats	10951
@NP	NSC transplantation	10966
@NP	the recovery of voluntary movements	10987
@NP	the recovery	10987
@NP	voluntary movements	11003
@NP	the second week of monitoring	11057
@NP	the second week	11057
@NP	monitoring	11076
@NP	The mean increase in BBB score in the experimental group	11088
@NP	The mean increase	11088
@NP	BBB score in the experimental group	11109
@NP	BBB score	11109
@NP	the experimental group	11122
@NP	4.5 ±	11149
@NP	0.4 vs. 2.5 ± 0.3	11153
@NP	0.4	11153
@NP	2.5 ± 0.3	11161
@NP	the control -LRB- p ≤ 0.02 -RRB-	11172
@NP	the control	11172
@NP	p ≤ 0.02	11185
@NP	p	11185
@NP	≤ 0.02	11186
@NP	30 days and 5.8 ± 0.3 vs. 4.5 ± 0.3 -LRB- p ≤ 0.002 -RRB-	11199
@NP	30 days	11199
@NP	5.8 ± 0.3 vs. 4.5 ± 0.3 -LRB- p ≤ 0.002 -RRB-	11211
@NP	5.8 ±	11211
@NP	0.3 vs. 4.5 ± 0.3 -LRB- p ≤ 0.002 -RRB-	11215
@NP	0.3	11215
@NP	4.5 ± 0.3 -LRB- p ≤ 0.002 -RRB-	11223
@NP	4.5 ± 0.3	11223
@NP	p ≤ 0.002	11232
@NP	p	11232
@NP	≤ 0.002	11233
@NP	60 days	11247
@NP	The positive effect of NSC transplantation on recovery of voluntary movements	11256
@NP	The positive effect	11256
@NP	NSC transplantation on recovery of voluntary movements	11279
@NP	NSC transplantation	11279
@NP	recovery of voluntary movements	11302
@NP	recovery	11302
@NP	voluntary movements	11314
@NP	the analysis	11356
@NP	relative parameters	11372
@NP	The percent of animals with BBB	11392
@NP	The percent	11392
@NP	animals with BBB	11407
@NP	animals	11407
@NP	BBB	11420
@NP	≥ 13	11430
@NP	the control and experimental groups	11437
@NP	the control	11437
@NP	experimental groups	11453
@NP	30 days	11479
@NP	0 and 50 % -LRB- p ≤ 0.05 -RRB-	11491
@NP	0	11491
@NP	50 % -LRB- p ≤ 0.05 -RRB-	11497
@NP	50 %	11497
@NP	p ≤ 0.05	11502
@NP	p	11502
@NP	≤ 0.05	11503
@NP	60 days	11531
@NP	the corresponding values	11539
@NP	25 and 84 % -LRB- p ≤ 0.05 -RRB-	11569
@NP	25 and 84 %	11569
@NP	p ≤ 0.05	11581
@NP	p	11581
@NP	≤ 0.05	11582
@NP	the experimental group	11593
@NP	the percent	11617
@NP	animals	11632
@NP	maximum increase in this parameter -LRB- > 5 -RRB- 60 days after CTSC	11645
@NP	maximum increase	11645
@NP	this parameter -LRB- > 5 -RRB- 60 days after CTSC	11665
@NP	this parameter -LRB- > 5 -RRB-	11665
@NP	this parameter	11665
@NP	> 5	11681
@NP	60 days	11685
@NP	CTSC	11699
@NP	the control : 100 and 38 % , respectively	11741
@NP	the control	11741
@NP	100 and 38 %	11754
@NP	100	11754
@NP	38 %	11762
@NP	p	11781
@NP	≤ 0.05	11782
@NP	Transplantation of NSC	11790
@NP	Transplantation	11790
@NP	NSC	11809
@NP	the time of hol ding	11823
@NP	the time	11823
@NP	hol ding	11835
@NP	the rotating rod	11847
@NP	the rota-rod apparatus	11867
@NP	the corresponding parameter	11902
@NP	the control group throughout the monitoring period	11933
@NP	the control group	11933
@NP	the monitoring period	11962
@NP	these changes	11989
@NP	Fig. 1	12037
@NP	b	12045
@NP	The tendency to improvement of locomotor function after trans plantation of NSC	12049
@NP	The tendency	12049
@NP	improvement of locomotor function after trans plantation of NSC	12065
@NP	improvement	12065
@NP	locomotor function after trans plantation of NSC	12080
@NP	locomotor function	12080
@NP	trans plantation of NSC	12105
@NP	trans plantation	12105
@NP	NSC	12125
@NP	appreciable increase	12146
@NP	the percent	12170
@NP	rats	12185
@NP	the rotating rod -LRB- 21 rpm -RRB- from 63 % in the control group	12212
@NP	the rotating rod -LRB- 21 rpm -RRB-	12212
@NP	the rotating rod	12212
@NP	21 rpm	12230
@NP	63 % in the control group	12243
@NP	63 %	12243
@NP	the control group	12250
@NP	100 % in the experimental group	12271
@NP	100 %	12271
@NP	the experimental group	12279
@NP	the end of the experiment	12305
@NP	the end	12305
@NP	the experiment	12316
@NP	Transplantation of NSC	12332
@NP	Transplantation	12332
@NP	NSC	12351
@NP	the mean distance	12370
@NP	error-free walking along the narrowing beam -LRB- Fig. 1 , c -RRB-	12391
@NP	error-free walking	12391
@NP	the narrowing beam -LRB- Fig. 1 , c -RRB-	12416
@NP	the narrowing beam	12416
@NP	Fig. 1	12436
@NP	c	12444
@NP	Signi cant differences from the control in this parameter	12448
@NP	Signi cant differences	12448
@NP	the control in this parameter	12477
@NP	the control	12477
@NP	this parameter	12492
@NP	the first 2 weeks of testing	12533
@NP	the first 2 weeks	12533
@NP	testing	12554
@NP	This	12563
@NP	intraparenchymatous transplantation of NSC in the acute period of CTSC	12582
@NP	intraparenchymatous transplantation	12582
@NP	NSC in the acute period of CTSC	12621
@NP	NSC	12621
@NP	the acute period of CTSC	12628
@NP	the acute period	12628
@NP	CTSC	12648
@NP	a short-term neuroprotective effect	12662
@NP	Analysis	12699
@NP	the relative number	12711
@NP	animals walking more than 50 cm along the narrowing beam without errors	12734
@NP	animals	12734
@NP	more than 50 cm along the narrowing beam	12750
@NP	more than 50 cm	12750
@NP	the narrowing beam	12772
@NP	errors	12799
@NP	positive effect of NSC transplantation	12822
@NP	positive effect	12822
@NP	NSC transplantation	12841
@NP	hind limb coordination	12864
@NP	the experimental group	12891
@NP	the percent	12915
@NP	animals	12930
@NP	≥ 50 cm along the narrowing beam	12946
@NP	≥ 50 cm	12946
@NP	the narrowing beam	12959
@NP	errors after 30 and 60 days	12986
@NP	errors	12986
@NP	30 and 60 days	12999
@NP	the corresponding parameter	13024
@NP	the control group	13055
@NP	5 and 2 times	13076
@NP	Calculation	13105
@NP	NSC transplantation efficiency	13120
@NP	comparison	13156
@NP	the number	13170
@NP	rats	13184
@NP	considerable recovery	13194
@NP	impaired functions -LRB- above the mean values in the control group -RRB-	13219
@NP	impaired functions	13219
@NP	the mean values in the control group	13245
@NP	the mean values	13245
@NP	the control group	13264
@NP	the end of the experiment	13286
@NP	the end	13286
@NP	the experiment	13297
@NP	considerable therapeutic effect	13321
@NP	the parameters of voluntary movements -LRB- BBB scale -RRB-	13356
@NP	the parameters	13356
@NP	voluntary movements -LRB- BBB scale -RRB-	13374
@NP	voluntary movements	13374
@NP	BBB scale	13395
@NP	improvement	13413
@NP	tests -LRB- rota-rod and narrowing beam -RRB-	13445
@NP	tests	13445
@NP	rota-rod and narrowing beam	13452
@NP	rota-rod	13452
@NP	narrowing beam	13465
@NP	Table 1	13514
@NP	Morphological analysis of CTSC zone	13524
@NP	Morphological analysis	13524
@NP	CTSC zone	13550
@NP	the character	13572
@NP	the volume of damage to the gray and white matter in experimental rats	13590
@NP	the volume	13590
@NP	damage to the gray and white matter in experimental rats	13604
@NP	damage	13604
@NP	the gray and white matter in experimental rats	13614
@NP	the gray and white matter	13614
@NP	experimental rats	13643
@NP	medium-severity CTSC -LRB- weight fall from a height of 12.5 mm -RRB-	13677
@NP	medium-severity CTSC	13677
@NP	weight fall from a height of 12.5 mm	13699
@NP	weight fall	13699
@NP	a height of 12.5 mm	13716
@NP	a height	13716
@NP	12.5 mm	13728
@NP	4 -RSB-	13738
@NP	CFDA-SE-labeled NSC transplanted into the spinal cord	13742
@NP	CFDA-SE-labeled NSC	13742
@NP	the spinal cord	13780
@NP	at least 7 days	13812
@NP	Their migration along the periphery of the lesion focus in the spinal cord	13829
@NP	Their migration	13829
@NP	the periphery of the lesion focus in the spinal cord	13851
@NP	the periphery	13851
@NP	the lesion focus in the spinal cord	13868
@NP	the lesion focus	13868
@NP	the spinal cord	13888
@NP	Transplantation of NSC 5 mm rostrally and caudally to the lesion epicenter	13918
@NP	Transplantation	13918
@NP	NSC 5 mm	13937
@NP	the lesion epicenter	13972
@NP	the formation of pathological cavities	14017
@NP	the formation	14017
@NP	pathological cavities	14034
@NP	the anterior funiculus of the white matter -LRB- Fig. 2 , b -RRB-	14059
@NP	the anterior funiculus	14059
@NP	the white matter -LRB- Fig. 2 , b -RRB-	14085
@NP	the white matter	14085
@NP	Fig. 2	14103
@NP	b	14111
@NP	This phenomenon	14115
@NP	sites	14154
@NP	the epicenter of the lesion -LRB- Fig. 2 , a -RRB-	14172
@NP	the epicenter	14172
@NP	the lesion -LRB- Fig. 2 , a -RRB-	14189
@NP	the lesion	14189
@NP	Fig. 2 , a	14201
@NP	Fig. 2	14201
@NP	a	14209
@NP	the neuroprotective effect of NSC transplantation	14241
@NP	the neuroprotective effect	14241
@NP	NSC transplantation	14271
@NP	the periphery of lesion site in the spinal cord tissue	14294
@NP	the periphery	14294
@NP	lesion site in the spinal cord tissue	14311
@NP	lesion site	14311
@NP	the spinal cord tissue	14326
@NP	NSC transplantation	14350
@NP	a positive effect on the process of posttraumatic remyelination	14379
@NP	a positive effect	14379
@NP	the process of posttraumatic remyelination	14400
@NP	the process	14400
@NP	posttraumatic remyelination	14415
@NP	The amount	14444
@NP	myelin fibers	14458
@NP	the lesion area -LRB- 3 mm from the epicenter -RRB- in the experimental group	14475
@NP	the lesion area -LRB- 3 mm from the epicenter -RRB-	14475
@NP	the lesion area	14475
@NP	3 mm from the epicenter	14492
@NP	3 mm	14492
@NP	the epicenter	14502
@NP	the experimental group	14520
@NP	the corresponding parameter	14553
@NP	controls -LRB- Fig. 2 , c -RRB-	14584
@NP	controls	14584
@NP	Fig. 2	14594
@NP	c	14602
@NP	the same time	14609
@NP	this effect	14624
@NP	the analysis of spinal cord sections	14656
@NP	the analysis	14656
@NP	spinal cord sections	14672
@NP	greater distance	14696
@NP	the epicenter -LRB- 5 mm , Fig. 2 , d -RRB-	14718
@NP	the epicenter	14718
@NP	5 mm	14733
@NP	Fig. 2	14739
@NP	d	14747
@NP	additional trauma	14777
@NP	this level caused by injection of the cell preparation at this site	14798
@NP	this level	14798
@NP	injection of the cell preparation	14819
@NP	injection	14819
@NP	the cell preparation	14832
@NP	this site	14856
@NP	the area of the white and gray matter at a distance of 1 and 1.5 cm	14880
@NP	the area	14880
@NP	the white and gray matter at a distance of 1 and 1.5 cm	14892
@NP	the white and gray matter	14892
@NP	a distance of 1 and 1.5 cm	14921
@NP	a distance	14921
@NP	1 and 1.5 cm	14935
@NP	the epicenter of the trauma	14953
@NP	the epicenter	14953
@NP	the trauma	14970
@NP	no significant differences between the control and experimental groups	14990
@NP	no significant differences	14990
@NP	the control and experimental groups	15025
@NP	the control	15025
@NP	experimental groups	15041
@NP	Low	15062
@NP	absolute -LRB- mean -RRB- values	15066
@NP	mean	15076
@NP	locomotion recovery parameters in our experiments	15092
@NP	locomotion recovery parameters	15092
@NP	our experiments	15126
@NP	the results of previous experiments	15153
@NP	the results	15153
@NP	previous experiments	15168
@NP	cell therapy of spinal cord injuries -LSB- 3,7,10,11,13,15 -RSB-	15192
@NP	cell therapy	15192
@NP	spinal cord injuries -LSB- 3,7,10,11,13,15 -RSB-	15208
@NP	spinal cord injuries	15208
@NP	3,7,10,11,13,15 -RSB-	15230
@NP	Insufficient level of functional reparation	15248
@NP	Insufficient level	15248
@NP	functional reparation	15270
@NP	peculiar tissue damage in spinal cord injuries	15312
@NP	peculiar tissue damage	15312
@NP	spinal cord injuries	15338
@NP	disruption	15360
@NP	long nerve conduction pathways -LRB- corticospinal and rubrospinal tracts -RRB-	15374
@NP	long nerve conduction pathways	15374
@NP	corticospinal and rubrospinal tracts	15406
@NP	corticospinal	15406
@NP	rubrospinal tracts	15424
@NP	the absence of physiological -LRB- phylogenetic -RRB- mechanisms	15448
@NP	the absence	15448
@NP	physiological -LRB- phylogenetic -RRB- mechanisms	15463
@NP	their continuity	15517
@NP	12,14 -RSB-	15535
@NP	the efficiency of cell therapy of CTSC	15559
@NP	the efficiency	15559
@NP	cell therapy of CTSC	15577
@NP	cell therapy	15577
@NP	CTSC	15593
@NP	we	15598
@NP	the means of functional recovery parameters	15617
@NP	the means	15617
@NP	functional recovery parameters	15630
@NP	the percent of animals with recovery parameters	15666
@NP	the percent	15666
@NP	animals with recovery parameters	15681
@NP	animals	15681
@NP	recovery parameters	15694
@NP	the mean level in the control group	15720
@NP	the mean level	15720
@NP	the control group	15738
@NP	the end of the experiment -LRB- 60 days after surgery -RRB-	15759
@NP	the end	15759
@NP	the experiment -LRB- 60 days after surgery -RRB-	15770
@NP	the experiment	15770
@NP	60 days after surgery	15786
@NP	60 days	15786
@NP	surgery	15800
@NP	The efficiency	15810
@NP	NSC transplantation into the spncal cord during the acute stage of CTSC	15828
@NP	NSC transplantation	15828
@NP	the spncal cord during the acute stage of CTSC	15853
@NP	the spncal cord	15853
@NP	the acute stage of CTSC	15876
@NP	the acute stage	15876
@NP	CTSC	15895
@NP	62 %	15904
@NP	the BBB test -LRB- recovery of voluntary movements -RRB-	15911
@NP	the BBB test	15911
@NP	recovery of voluntary movements	15925
@NP	recovery	15925
@NP	voluntary movements	15937
@NP	32 and 37 % by load tests narrowing beam and rota-rod	15962
@NP	32 and 37 %	15962
@NP	load tests narrowing beam and rota-rod	15976
@NP	load tests	15976
@NP	beam and rota-rod	15997
@NP	These results	16030
@NP	an argument	16048
@NP	clinical testing of NSC preparation	16073
@NP	clinical testing	16073
@NP	NSC preparation	16093
@NP	CTSC	16112
@NP	the same time	16124
@NP	the question	16142
@NP	the necessity of search	16158
@NP	the necessity	16158
@NP	search	16175
@NP	new methods	16186
@NP	modulation	16201
@NP	phylogenetic sanogenetic mechanisms	16215
@NP	recovery of integral functions in spinal cord injuries	16263
@NP	recovery	16263
@NP	integral functions in spinal cord injuries	16275
@NP	integral functions	16275
@NP	spinal cord injuries	16297
@NP	The study	16319
@NP	the Russian Foundation	16346
@NP	Basic Research -LRB- grant 08-04-01167 and 07 - 04-00746 -RRB-	16373
@NP	Basic Research	16373
@NP	grant 08-04-01167 and 07 - 04-00746	16389
@NP	grant 08-04-01167	16389
@NP	07 - 04-00746	16411
@VP	Biologii i Meditsiny , Vol	316
@VP	pp. 355-360 , March , 2010	355
@VP	submitted April 29 , 2009	398
@VP	walking along a narrowing beam	703
@VP	were monitored weekly over 60 days	734
@VP	monitored weekly over 60 days	739
@VP	receiving cell transplantation	778
@VP	increased by 11 % by the end of the experiment	843
@VP	surpassed the corresponding parameters in controls	939
@VP	surpassing the corresponding mean values in the control groups	1085
@VP	receiving transplantation of human neural stem cells	1406
@VP	was minimum -LSB- 5,6,11 -RSB-	1755
@VP	used in practically all studies	1942
@VP	is at least 1-2 points for the 21-point scale -LSB- 4 -RSB-	2032
@VP	did not exceed 2-3 points compared to the control -LSB- 3,5-7,9-11,13 -RSB-	2277
@VP	exceed 2-3 points compared to the control -LSB- 3,5-7,9-11,13 -RSB-	2285
@VP	-LSB- 2 -RSB-	2533
@VP	were carried out on 53	2768
@VP	carried out on 53	2773
@VP	was approved by Ethical committee of Russian State Medical University	3059
@VP	approved by Ethical committee of Russian State Medical University	3063
@VP	was transferred to the laboratory in cold Ca2 +	3289
@VP	transferred to the laboratory in cold Ca2 +	3293
@VP	were repeatedly washed with the same buffer	3462
@VP	washed with the same buffer	3478
@VP	were removed	3521
@VP	removed	3526
@VP	buffered saline -LRB- pH 7.4 -RRB- at 36.5 oC for 40 min	3625
@VP	were blocked with DMEM -LRB- Gibco -RRB- containing 3 % serum	3684
@VP	blocked with DMEM -LRB- Gibco -RRB- containing 3 % serum	3689
@VP	containing 3 % serum	3715
@VP	washed 3 times with balanced Hanks saline	3751
@VP	dissociated by repeated pipetting in a nutrient medium	3797
@VP	was centrifuged at 1200 rpm for 7 min	4189
@VP	centrifuged at 1200 rpm for 7 min	4193
@VP	was resuspended in the same medium	4242
@VP	resuspended in the same medium	4246
@VP	containing 90-95 % viable cells	4300
@VP	were used for further culturing	4331
@VP	used for further culturing	4336
@VP	were cultured in 12-well plates on polylysine-coated substrate for 14 h.	4382
@VP	cultured in 12-well plates on polylysine-coated substrate for 14 h.	4387
@VP	was half-replaced twice a week	4466
@VP	attaining a confluent state	4524
@VP	harvested with trypsin-EDTA -LRB- 0.25 % -RRB-	4556
@VP	washed in Hanks balanced saline solution -LRB- HBSS -RRB-	4593
@VP	centrifuged	4642
@VP	resuspended in nutrient medium	4659
@VP	was transferred to 25 - cm flasks	4711
@VP	transferred to 25 - cm flasks	4715
@VP	Freely floating and attached to the substrate neurospheres	4745
@VP	Freely floating	4745
@VP	attached to the substrate neurospheres	4765
@VP	were collected and dissociated by enzyme treatment	4804
@VP	collected and dissociated by enzyme treatment	4809
@VP	attached to the substrate	4985
@VP	were thus subcultured 4 times	5025
@VP	subcultured 4 times	5035
@VP	was frozen and stored in liquid nitrogen	5096
@VP	frozen and stored in liquid nitrogen	5100
@VP	was > 95 %	5513
@VP	was prepared	5604
@VP	prepared	5608
@VP	was rapidly -LRB- within 5 min -RRB- delivered to the operation room	5645
@VP	delivered to the operation room	5672
@VP	did not exceed 1.5 h.	5733
@VP	exceed 1.5 h.	5741
@VP	was stored at 4 °C	5790
@VP	stored at 4 °C	5794
@VP	was modeled as described elsewhere -LSB- 8 -RSB-	5814
@VP	modeled as described elsewhere -LSB- 8 -RSB-	5818
@VP	described elsewhere -LSB- 8 -RSB-	5829
@VP	fixed with metal clips by the spinous processes of vertebrae Th8 and Th10	6008
@VP	fixed in a stereotaxis micromanipulator	6173
@VP	falling vertically from a height of 12.5 mm	6217
@VP	occurred along the central line of the spinal cord at the boundary with Th8	6290
@VP	was carried out	6389
@VP	carried out	6393
@VP	were transplanted into two points at the bondaries with Th7 and Th10	6413
@VP	transplanted into two points at the bondaries with Th7 and Th10	6418
@VP	to avoid damage to the central channel of the spinal cord	6594
@VP	avoid damage to the central channel of the spinal cord	6597
@VP	consisted of 30 rats	6763
@VP	received Hanks solution under the same conditions	6805
@VP	connected to a micropump	6899
@VP	Stoelting o.	6925
@VP	was used	6940
@VP	used	6944
@VP	were injected to a depth of 1.2 mm	6960
@VP	injected to a depth of 1.2 mm	6965
@VP	was 10 µ/sec	7028
@VP	was 1 µl/min	7064
@VP	was withdrawn 5 min after the end of transplantation	7089
@VP	withdrawn 5 min after the end of transplantation	7093
@VP	was sutured layer-by-layer	7163
@VP	were not administered	7203
@VP	administered	7212
@VP	was forced by pressing the abdominal wall above the urinary bladder	7265
@VP	forced by pressing the abdominal wall above the urinary bladder	7269
@VP	pressing the abdominal wall above the urinary bladder	7279
@VP	were tested weekly at the same time of the day for 2 consecutive days	7343
@VP	tested weekly at the same time of the day for 2 consecutive days	7348
@VP	were assessed	7516
@VP	assessed	7521
@VP	was evaluated -LSB- 2 -RSB-	7564
@VP	evaluated -LSB- 2 -RSB-	7568
@VP	were carried out on a biomaterial taken 7 , 30 , and 60 days after trauma	7605
@VP	carried out on a biomaterial taken 7 , 30 , and 60 days after trauma	7610
@VP	taken 7 , 30 , and 60 days after trauma	7639
@VP	were narcotized -LRB- 200 mg/kg ketamine intraperitoneally -RRB-	7690
@VP	narcotized -LRB- 200 mg/kg ketamine intraperitoneally -RRB-	7695
@VP	was taken	7964
@VP	taken	7968
@VP	were numbered starting from the caudal one	8047
@VP	numbered starting from the caudal one	8052
@VP	postdixed in 2.5 % glutaraldehyde and 1 % OsO4	8118
@VP	dehydrated	8164
@VP	embedded in epon 812	8179
@VP	were fixed in 10 % neutral formalin , dehydrated , and embedded in paraffin	8219
@VP	fixed in 10 % neutral formalin , dehydrated , and embedded in paraffin	8224
@VP	dehydrated , and embedded in paraffin	8255
@VP	dehydrated	8255
@VP	embedded in paraffin	8271
@VP	prepared on an LKB III microtome and stained with methylene blue	8492
@VP	prepared on an LKB III microtome	8492
@VP	stained with methylene blue	8529
@VP	was measured on paraffin sections	8658
@VP	measured on paraffin sections	8662
@VP	stained with CFDA-SE -LRB- Invitrogen -RRB- in 5 µl Hanks medium	9107
@VP	were transplanted to 5 experimental rats into 2 above described points	9162
@VP	transplanted to 5 experimental rats into 2 above described points	9167
@VP	were labeled immediately before transplantation	9244
@VP	labeled immediately before transplantation	9249
@VP	buffered saline for 15 min at 37 °C and then in DMEM for 30 min at 37oC	9370
@VP	was taken on day 7 and frozen for preparing cryostat sections	9474
@VP	taken on day 7 and frozen for preparing cryostat sections	9478
@VP	taken on day 7	9478
@VP	frozen for preparing cryostat sections	9497
@VP	preparing cryostat sections	9508
@VP	TABLE 1	9660
@VP	Open bars : experiment ; dark bars : control	10365
@VP	had little effect on body weight gain	10573
@VP	was 448 ± 12 g in the control group and 449 ± 15 g in the experimental group	10653
@VP	receiving NSC transplantation	10956
@VP	was more pronounced starting from the second week of monitoring	11023
@VP	was 0 and 50 % -LRB- p ≤ 0.05 -RRB- , respectively	11487
@VP	were 25 and 84 % -LRB- p ≤ 0.05 -RRB-	11564
@VP	were statistically insignificant -LRB- Fig. 1 , b -RRB-	12003
@VP	staying on the rotating rod -LRB- 21 rpm -RRB- from 63 % in the control group	12201
@VP	were observed only during the first 2 weeks of testing	12507
@VP	observed only during the first 2 weeks of testing	12512
@VP	provides a short-term neuroprotective effect	12653
@VP	walking more than 50 cm along the narrowing beam without errors	12742
@VP	attests to positive effect of NSC transplantation on hind limb coordination	12811
@VP	walking ≥ 50 cm along the narrowing beam without errors after 30 and 60 days	12938
@VP	was statistically insignificant -LRB- Table 1 -RRB-	13481
@VP	transplanted into the spinal cord	13762
@VP	were viable for at least 7 days	13796
@VP	was observed	13904
@VP	observed	13908
@VP	had a positive effect on the process of posttraumatic remyelination	14375
@VP	surpassed the corresponding parameter in controls -LRB- Fig. 2 , c -RRB-	14543
@VP	caused by injection of the cell preparation at this site	14809
@VP	revealed no significant differences between the control and experimental groups	14981
@VP	restoring their continuity -LSB- 12,14 -RSB-	15507
@VP	evaluating the efficiency of cell therapy of CTSC	15548
@VP	narrowing beam and rota-rod	15987
@VP	involved in recovery of integral functions in spinal cord injuries	16251
